Semaglutide — GLP-1 Metabolic Peptide
2mg • 5mg • 10mg
Semaglutide is a long-acting GLP-1 (Glucagon-Like Peptide-1) receptor agonist
widely used in metabolic and weight-management research. By enhancing satiety signaling,
reducing appetite, and improving glucose regulation, semaglutide supports
sustainable fat loss, improved insulin sensitivity, and
better metabolic control. Its extended half-life allows for convenient
once-weekly administration, making it one of the most established GLP-1 compounds available.
✅ Product Overview
| Compound | Semaglutide |
| Compound Class | GLP-1 receptor agonist |
| Available Strengths | 2mg • 5mg • 10mg (total peptide content) |
| Primary Research Focus | Appetite control, weight reduction, glucose regulation, insulin sensitivity |
| Typical Administration | Once weekly (long-acting peptide) |
🧠 Mechanism of Action — How Semaglutide Works
0
- GLP-1 receptor activation: Enhances satiety signaling in the brain,
reducing hunger and caloric intake. - Delayed gastric emptying: Slows digestion, helping control post-meal
glucose spikes and prolonging fullness. - Glucose-dependent insulin secretion: Supports insulin release when
blood glucose is elevated while suppressing excess glucagon. - Improved insulin sensitivity: Supports better metabolic efficiency
over time.
📅 Dosing & Titration (Educational Reference)
Semaglutide is typically introduced using a slow titration model to
minimize gastrointestinal side effects. The following reflects commonly referenced
educational protocols.
- Initial phase: Very low introductory dosing
- Adaptation phase: Gradual increases every 3–4 weeks
- Maintenance phase: Stable weekly dose once tolerance is established
Key principle: Slower escalation improves comfort and adherence.
Higher doses are not required for everyone.
🥗 Dietary & Lifestyle Recommendations
- Protein-focused meals: Helps preserve lean mass during weight loss.
- Smaller meal portions: Reduces nausea and digestive discomfort.
- Moderate fat intake: Very high-fat meals may worsen GI symptoms.
- Hydration & electrolytes: Important when appetite is significantly reduced.
- Resistance training: Supports metabolic rate and muscle retention.
⚠️ Contraindications & Cautions
- Personal or family history of medullary thyroid carcinoma (MTC)
- MEN-2 (Multiple Endocrine Neoplasia type 2)
- History of pancreatitis
- Severe gastrointestinal disease
- Pregnancy or breastfeeding
💊 Medication Interactions
- Other GLP-1 receptor agonists
- Insulin or insulin secretagogues (increased hypoglycemia risk)
- Oral medications with narrow absorption windows
- Oral contraceptives (effectiveness may be reduced during titration)
😵 Commonly Reported Effects
- Nausea
- Reduced appetite
- Constipation or diarrhea
- Fatigue during early titration
- Injection-site irritation
🧾 Important Notice
This product description is provided for educational and research purposes only.
Semaglutide is a prescription medication in many jurisdictions. Information presented here
is not medical advice and is not intended to diagnose, treat, cure, or prevent any disease.
All metabolic compounds should be used only with appropriate knowledge, monitoring,
and professional oversight.
